Medicare will continue its cautious approach to paying for Alzheimer’s drugs

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

AAM picks up laid-off BIO exec

Redox reactions – when an atom loses an electron that is picked up by another atom– are common to some basic functions of life, including photosynthesis, respiration, combustion. A similar process is also common to life in Washington, where one trade group loses an executive that is picked up by another trade group, my colleague John Wilkerson writes.

The Association for Accessible Medicines announced Wednesday that it hired John Murphy as its new CEO, John and I scooped yesterday. Murphy previously was the chief policy officer at the Biotechnology Innovation Organization, and was laid off in May as part of a major reorganization under BIO’s new CEO.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In